A Boston-based company that recently completed an expansion in Research Triangle Park is now laying off a big chunk of its workforce, joining a list of biotechs that have scaled back operations amid uneasy market conditions.
A Boston-based company that recently completed an expansion in Research Triangle Park is now laying off a big chunk of its workforce, joining a list of biotechs that have scaled back operations amid uneasy market conditions.
